Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
In an era of precision medicine, it seems regressive that we do not use stratified approaches to direct treatment of oral corticosteroids during an exacerbation of chronic obstructive pulmonary disease (COPD). This is despite evidence suggesting that 40% of COPD patients have eosinophilic inflammati...
Main Authors: | Camp, J, Cane, J, Bafadhel, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2018
|
Similar Items
-
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018) -
Seasonality of eosinophilic and non-eosinophilic exacerbations of COPD
by: Barker, R, et al.
Published: (2017) -
The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
by: Russell, R, et al.
Published: (2019) -
Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014) -
Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)